As creators of in-vitro diagnostic solutions, we offer innovative products that span a broad range of technologies and application areas such as clinical chemistry, immunochemistry, polymerase chain reaction (PCR), and our latest addition mass spectrometry. With unique medical, pharmaceutical, and scientific expertise, we deliver meaningful, medically relevant answers to improve people’s lives since 1978 with the launch of cobas® Bio.
By redefining the possible, we prioritize patient needs and unmet medical requirements. Our close collaboration with customers ensures that our innovations address critical needs. We meticulously validate solutions with real clinical evidence, developing diagnostic solutions that seamlessly integrate innovative engineering and information technology, shaping the laboratories of the future and beyond.
Healthcare is not a privilege, it’s a right. That’s why our mission with the cobas® portfolio is to make diagnostics what it should be, a powerful connector between patient needs and sustainable healthcare.
Our core lab portfolio from cobas® has been designed to seamlessly connect different testing disciplines, providing automated, integrated, and tailored solutions across a wide range of laboratory and healthcare settings.
The cobas® molecular portfolio goes beyond pioneering PCR technology, pathogen detection, and viral load monitoring. Our dedication to research and development allows us to deliver a complete, end-to-end solution tailored to your lab's needs, ensuring the highest quality care for your patients.
Deliver robust and immediate results outside your central lab where needed, when needed. From blood gas and electrolyte testing to coagulation and blood glucose monitoring, we offer solutions that generate actionable insights and meaningful outcomes for you and your patients.
